We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 61

Ukraine Healthcare Industry Group Newsletter - January 2017
  • Baker McKenzie
  • Ukraine
  • January 2 2017

As reported in the previous issue of our Newsletter, on 9 November 2016, the Cabinet of Ministers of Ukraine (the "CMU") approved regulations "On the


Parallel importation of pharmaceutical products
  • Marks & Clerk
  • United Kingdom
  • July 5 2016

The question of parallel importation of pharmaceutical products has recently been considered by the Chancery Division of the UK’s High Court in the


Turkey: Pharmaceutical trademarks: regulation, parallel imports and advertising
  • Kenaroğlu Intellectual Property
  • Turkey
  • July 1 2016

The key feature of pharmaceutical trademarks is that they should provide insight into the main active ingredients of the products to which they are


Final WHO Biosimilar Naming Proposal Resembles FDA Approach
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • February 3 2016

On January 26, 2016, the World Health Organization (WHO) unveiled the final version of its proposal for a worldwide biosimilar naming convention. The


Trademarks for the Pharmaceutical Sector in Turkey
  • Moroğlu Arseven
  • Turkey
  • October 1 2015

Pharmaceutical trademark owners consider many factors when selecting a trademark. As it assists consumers’ decision-making process, a trademark often


Supreme Court ruling on marks similar to pharma INNs
  • Tilleke & Gibbins
  • Thailand
  • March 9 2015

In Thailand, the names ascribed by generic drug manufacturers to their pharmaceutical products are often similar to the names of pharmaceutical


International Non-Proprietary Names as trademarks in India INN or out?
  • Selvam and Selvam
  • India
  • October 14 2014

International Non-Proprietary Names (INN) are globally recognized names for pharmaceutical substances or active pharmaceutical ingredients and are


Australian Trade Marks Office's fusion on INN Stems
  • Spruson & Ferguson
  • Australia
  • October 9 2013

The Australian Trade Marks Office has, in recent years, taken a very strict approach with regard to pharmaceutical trade marks that include a word


Germany
  • BARDEHLE PAGENBERG
  • Germany
  • September 17 2013

On the regulatory side, the Federal Institute for Drugs and Medical Devices is the authority competent to grant a national marketing authorisation for


Greece
  • Vayanos Kostopoulos
  • Greece
  • September 17 2013

The most important legislative sources for pharmaceutical trademarks are: the new Trademarks Law (40722012), as modified by Law 41552013